The prevalence of obesity around the world has boosted the need for efficient therapies and drugs, including anti-obesity drugs. Pharmaceutical interventions are becoming more and more necessary as obesity rates rise to address these public health concerns.Wilmington, Delaware, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Global Anti-Obesity Drugs Market is valued at US$ 2.82 billion in 2022 and is expected to grow at a significant CAGR of over 23% over the forecast period of 2023-2030, market report by Ra

Related Keywords

Indonesia , Ukraine , Delaware , United States , Brazil , Poland , Canada , France , China , India , Hungary , Thailand , South Africa , Germany , Japan , Nigeria , South Korea , Mexico , Italy , United Arab Emirates , Spain , Vietnam , Republic Of , Australia , Russia , Saudi Arabia , Philippines , Turkey , United Kingdom , Malaysia , America , Asia Pacific , Novo Nordisk , Kimberly Shaw , Research Methodology , Merck Co , Arena Pharmaceuticals Inc , Boehringer Ingelheim International Gmb , Eisai Co , Glaxosmithkline , Roche Ltd , Currax Pharmaceuticals , Takeda Pharmaceuticals Company Ltd , European Union , Sandoz International Gmb , Pfizer Inc , Eli Lilly Company , Anti Obesity Drugs Market , Latin America , Western Europe , Eastern Europe , Middle East , Anti Obesity Drugs , Production Levels , Capacity Utilization , Market Share , Regional Economic Sentiment , North America , Market Structure , Hoffamann La Roche Ltd , Sandoz International Gmbh , Boehringer Ingelheim International Gmbh , Anti Obesity Drugsmarket Value , Arab Emirates , Questions Answered , Anti Obesity Drugsreport , Deep Down Insight , Kingdom Phone , Market Sizing , Market Size , Market Report , Forecast Period , Market Intelligence , Market Scope , Anti Obesity Medications ,